Financhill
Back

Cronos Group Quote, Financials, Valuation and Earnings

Cronos Group Price Quote

$1.96
+0.00 (+4.81%)
(Updated: December 21, 2024 at 5:21 AM ET)

Cronos Group Key Stats

Sell
29
Cronos Group (CRON) is a Sell

Day range:
$1.86 - $1.97
52-week range:
$1.86 - $3.14
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
6.73
P/B ratio:
0.69%

Volume:
1.9M
Avg. volume:
1.3M
1-year change:
5.11%
Market cap:
$747.4M
Revenue:
$87.2M
EPS:
$-0.12

How Much Does Cronos Group Make?

Data Unavailable

Is Cronos Group Growing As A Company?

Data Unavailable

Cronos Group Stock Price Performance

  • Did Cronos Group Stock Go Up Last Month?
    Cronos Group share price went down by -2.74% last month
  • Did CRON's Share Price Rise Over The Last Year?
    CRON share price rose by 5.11% over the past 1 year

What Is Cronos Group 52-Week High & Low?

Cronos Group Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cronos Group?

Data Unavailable

Is Cronos Group Cash Flow Positive?

Data Unavailable

Cronos Group Return On Invested Capital

Data Unavailable

Cronos Group Earnings Date & Stock Price

  • What Is Cronos Group's Stock Price Today?
    A single share of CRON can be purchased today for 1.96
  • What Is Cronos Group’s Stock Symbol?
    Cronos Group trades on the nasdaq under the ticker symbol: CRON
  • When Is Cronos Group’s Next Earnings Date?
    The next quarterly earnings date for Cronos Group is scheduled on February 28, 2025
  • When Is CRON's next ex-dividend date?
    Cronos Group's next ex-dividend date is December 22, 2024
  • How To Buy Cronos Group Stock?
    You can buy Cronos Group shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Cronos Group Competitors

  • Who Are Cronos Group's Competitors?
    Below is a list of companies who compete with Cronos Group or are related in some way:
    • Aurinia Pharmaceuticals Inc (AUPH)
    • Edesa Biotech Inc (EDSA)
    • Lexaria Bioscience Corp (LEXX)
    • Tilray Brands Inc (TLRY)
    • Xenon Pharmaceuticals Inc (XENE)

Cronos Group Dividend Yield

Data Unavailable

Cronos Group Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 95.98%
Revenue: 38.11% 12.24%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

Data Unavailable